HRT and ovarian cancer




Menopausal hormone therapy treatment options and ovarian cancer risk: A Swedish prospective populationbased matchedcohort study

 Menopausal hormone replacement therapy (HRT) influences ovarian cancer. This survey of all Swedish women who received HRT between 2005-2012 looks at risk. HRT can be oestrogen only or combined oestrogen/progesterone, cutaneous administration is available. Some HRT is continuous some sequential. 

The incidence of ovarian cancer was obtained from the Swedish Cancer Register. The therapy group was compared with a larger control group of women who did not receive HRT.

Current users of continuous combined HRT have a small increased risk being 1.4 times more likely to develop ovarian cancer. This risk is reduced by cutaneous therapy. Oestrogen only HRT is protective with a reduced incidence of ovarian cancer. There is no increased risk with sequential therapy. Once HRT is discontinued there is no increased risk.


Comments

Popular posts from this blog

An impossible dream?

It’s not just your genotype

Sugar doesn’t feed cancer